Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 728612

Circulating Her-2/Neu Extracellular Domain in Breast Cancer Patients-Correlation with Prognosis and Clinicopathological Parameters Including Steroid Receptor, Her- 2/Neu Receptor Coexpression


Barić, Marina; Kulić, Ana; Sirotković- Skerlev, Maja; Dedić Plavetić, Natalija; Vidović, Marina; Horvatić-Herceg, Gordana; Vrbanec, Damir
Circulating Her-2/Neu Extracellular Domain in Breast Cancer Patients-Correlation with Prognosis and Clinicopathological Parameters Including Steroid Receptor, Her- 2/Neu Receptor Coexpression // Pathology oncology research, 21 (2015), 3; 589-595 doi:10.1007/s12253-014-9859-6 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 728612 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Circulating Her-2/Neu Extracellular Domain in Breast Cancer Patients-Correlation with Prognosis and Clinicopathological Parameters Including Steroid Receptor, Her- 2/Neu Receptor Coexpression

Autori
Barić, Marina ; Kulić, Ana ; Sirotković- Skerlev, Maja ; Dedić Plavetić, Natalija ; Vidović, Marina ; Horvatić-Herceg, Gordana ; Vrbanec, Damir

Izvornik
Pathology oncology research (1219-4956) 21 (2015), 3; 589-595

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
HER-2/neu ECD; Breast cancer; Prognosis; Steroid receptor/HER-2/neu receptor coexpression

Sažetak
HER-2/neu extracellular domain (ECD) can be detected in blood as a soluble circulating protein. The aim of this study was to analyze the relationship between HER-2/neu extracellular domain in the serum and the prognosis in breast cancer patients. We also correlated HER-2/neu ECD with various clinicopathological factors including steroid receptor, HER-2/neu receptor coexpression. The serum from seventy nine patients with invasive breast cancer and twenty individuals without malignancy was analyzed using the enzymelinked immune adsorbent assay method. The cut-off value was estimated by the ROC curve analysis (15.86 μg/L). HER-2/neu ECD values in the serum of patients with breast cancer were significantly higher than in control subjects. Circulating HER-2/neu ECD was significantly associated with the histological grade of tumors and the status of axillary lymph nodes. Negative correlation was observed between HER- 2/neu ECD in the serumand estrogen receptor positivity. When we analyzed HER-2/neu ECD in relation with coexpression of steroid receptor and HER-2/neu receptor in tissue, statistically higher values were found in the subgroup of patients with steroid receptor negative, HER- 2/neu negative tumors than in the other subgroups. HER-2/neu ECD was not an independent factor in the univariate and multivariate analysis. However, elevated HER-2/neu ECD levels were found in patients with breast cancer possessing more aggressive phenotype.

Izvorni jezik
Engleski

Znanstvena područja
Biologija, Temeljne medicinske znanosti, Kliničke medicinske znanosti



POVEZANOST RADA


Projekti:
108-1080058-0046 - KARCINOM DOJKE-MOLEKULARNE,GENETSKE I KLINIČKE KARAKTERISTIKE (Vrbanec, Damir, MZOS ) ( POIROT)

Ustanove:
Medicinski fakultet, Zagreb,
Klinički bolnički centar Zagreb

Citiraj ovu publikaciju

Barić, Marina; Kulić, Ana; Sirotković- Skerlev, Maja; Dedić Plavetić, Natalija; Vidović, Marina; Horvatić-Herceg, Gordana; Vrbanec, Damir
Circulating Her-2/Neu Extracellular Domain in Breast Cancer Patients-Correlation with Prognosis and Clinicopathological Parameters Including Steroid Receptor, Her- 2/Neu Receptor Coexpression // Pathology oncology research, 21 (2015), 3; 589-595 doi:10.1007/s12253-014-9859-6 (međunarodna recenzija, članak, znanstveni)
Barić, M., Kulić, A., Sirotković- Skerlev, M., Dedić Plavetić, N., Vidović, M., Horvatić-Herceg, G. & Vrbanec, D. (2015) Circulating Her-2/Neu Extracellular Domain in Breast Cancer Patients-Correlation with Prognosis and Clinicopathological Parameters Including Steroid Receptor, Her- 2/Neu Receptor Coexpression. Pathology oncology research, 21 (3), 589-595 doi:10.1007/s12253-014-9859-6.
@article{article, year = {2015}, pages = {589-595}, DOI = {10.1007/s12253-014-9859-6}, keywords = {HER-2/neu ECD, Breast cancer, Prognosis, Steroid receptor/HER-2/neu receptor coexpression}, journal = {Pathology oncology research}, doi = {10.1007/s12253-014-9859-6}, volume = {21}, number = {3}, issn = {1219-4956}, title = {Circulating Her-2/Neu Extracellular Domain in Breast Cancer Patients-Correlation with Prognosis and Clinicopathological Parameters Including Steroid Receptor, Her- 2/Neu Receptor Coexpression}, keyword = {HER-2/neu ECD, Breast cancer, Prognosis, Steroid receptor/HER-2/neu receptor coexpression} }
@article{article, year = {2015}, pages = {589-595}, DOI = {10.1007/s12253-014-9859-6}, keywords = {HER-2/neu ECD, Breast cancer, Prognosis, Steroid receptor/HER-2/neu receptor coexpression}, journal = {Pathology oncology research}, doi = {10.1007/s12253-014-9859-6}, volume = {21}, number = {3}, issn = {1219-4956}, title = {Circulating Her-2/Neu Extracellular Domain in Breast Cancer Patients-Correlation with Prognosis and Clinicopathological Parameters Including Steroid Receptor, Her- 2/Neu Receptor Coexpression}, keyword = {HER-2/neu ECD, Breast cancer, Prognosis, Steroid receptor/HER-2/neu receptor coexpression} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font